Pharmafile Logo
Pharmafocus logo
Advanced Search
christy_nolandweb

Astellas appoints comms head from Baxter

September 18, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris

Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …

Appointment
HealthKit image

Apple’s HealthKit plagued by bugs and delay

September 18, 2014
Medical Communications, Sales and Marketing Apple, Samsung, digital, google, health kit, ios8, wearables

Apple’s new mobile software iOS8 was launched around the world yesterday but the eagerly anticipated centrepiece HealthKit app was conspicuous …

News

GSK melanoma drug sees quick NICE nod

September 18, 2014
Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer

NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …

News

NICE reform put on hold – for now

September 17, 2014
Sales and Marketing Dillon, NHS, NHS England, NICE, market access, vba

The reforming of NICE has been put on hold as the watchdog believes more changes must be wrought to deal …

News
eric_hansen

New managing director for PAN

September 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston Health, Jon Linscott, Pan, eric hansen

Creative comms agency PAN has appointed a new managing director in Eric Hansen who replaces the recently-departed Jon Linscott.Reporting in …

Appointment

Cancer drug gains first early UK access grant

September 17, 2014
Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising

A new type of cell therapy for cancer has become the first to be deemed by the UK government as …

News
screen_shot_2014-09-17_at_07

Epic Sciences hires regulatory affairs VP

September 17, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing epic sciences, paul frieberg

San Diego-based cancer diagnostics firm Epic Sciences has appointed Glen Paul Freiberg as its vice president of regulatory affairs and …

Appointment
Pfizer image

Pfizer partners with MedGenesis on Parkinson’s

September 16, 2014
Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience

Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …

News

Pharma exports in UK help drive the economy

September 16, 2014
Manufacturing and Production, Sales and Marketing UK, emerging markets, exports, hsbc, imports, pharma

The UK’s pharmaceutical sector is ‘an export success story’, enjoying a competitive advantage and generating a sizeable trade surplus. This …

News
Kadcyla image

Roche should be ‘shamed’ into lowering cancer drug price

September 16, 2014
Medical Communications, Sales and Marketing Kadcyla, Margaret Connolly, Roche, Swiss, breast cancer, trastuzumab emtansine

A public petition to force Roche to lower the cost of its costly new breast cancer drug Kadcyla has been …

News
AZ image

AstraZeneca teams up with rival Lilly for Alzheimer’s

September 16, 2014
Research and Development, Sales and Marketing AZD3293, Alzheimer's, Alzheimer’s, AstraZeneca, BACE, lilly

AstraZeneca and US rival Lilly have signed an agreement to develop a new and experimental pill for the treatment of …

News
Sovaldi image

Gilead allows generic prices for Sovaldi

September 16, 2014
Manufacturing and Production, Sales and Marketing Gilead, hep C, hepatitis C, sofosbuvir, sovaldi

Gilead will allow Indian generic drug firms to make cheap copies of its new hepatitis C pill Sovaldi in an …

News

No silver bullet, but a growing arsenal for pharma comms

September 16, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lundbeck, comms, eyeforpharma, mcm, selincro, tim white

Digital strategies in the pharma industry have predominately been a red herring, focussing too much on the novelty of digital …

Feature
professor_roberto_pellicciari

Tiziana appoints Intercept head to its board

September 16, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing roberto pelliccaiari, tiziana

UK biotech firm Tiziana Life Sciences has confirmed that Professor Roberto Pellicciari is joining its scientific advisory board and will …

Appointment
nhs_parliament_2_8

UK pharma pays out £150m in drug rebates

September 12, 2014
Medical Communications, Sales and Marketing ABPI, PPRS, Roche, emms, rebate

The UK pharma industry has paid £150 million back to the government as part of its rebate to “underwrite the …

News
Victoza image

FDA panel backs liraglutide for obesity

September 12, 2014
Manufacturing and Production, Sales and Marketing Arena Pharmaceuticals, Belviq, Novo Nordisk, Qsymia, Victoza, Vivus, diabetes, obesity

An FDA panel has voted 14-1 to allow a form of Novo Nordisk’s type 2 diabetes treatment Victoza to help …

News

Google’s Calico takes first steps into research

September 12, 2014
Medical Communications, Sales and Marketing AbbVie, P7C3, Parkinson's, Parkinson’s, calico, depression, google, motor neurone disease

Google is finally shifting into gear within the health arena as it signs its first research deal to develop a …

News
ceneris

Cerenis announces board chairman

September 12, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cerenis

France and US-based biopharma firm Cerenis Therapeutics has confirmed the appointment of Dr Richard Pasternak as its chairman of the …

Appointment
Lilly image

Lilly and Boehringer diabetes biosimilar sees EU approval

September 11, 2014
Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly

Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …

News

FDA approves new indication for Xtandi

September 11, 2014
Sales and Marketing Astellas, FDA, Medivation, Xtandi, Zytiga, prostate

The FDA has approved Astellas Pharma and Medivation’s prostate cancer drug Xtandi (enzalutamide) for use in patients who have not …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026